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ABSTRACT
Pseudomonas aeruginosa is an opportunistic pathogen, known to develop robust biofilms. Its biofilm development increases
when antibiotics are presented at subminimal inhibitory concentrations (MICs) for reasons that remain unclear. In order to
identify genes that affect biofilm development under such a sublethal antibiotic stress condition, we screened a transposon
(Tn) mutant library of PAO1, a prototype P. aeruginosa strain. Among ∼5000 mutants, a fiuA gene mutant was verified to form
very defective biofilms in the presence of sub-MIC carbenicillin. The fiuA gene encodes ferrichrome receptor A, involved in
the iron acquisition process. Of note, biofilm formation was not decreased in the pchpvd mutant defective in the
production of pyochelin and pyoverdine, two well-characterized P. aeruginosa siderophore molecules. Moreover, fiuA, a
non-polar fiuA deletion mutant, produced a significantly decreased level of elastase, a major virulence determinant. Mouse
airway infection experiments revealed that the mutant expressed significantly less pathogenicity. Our results suggest that
the fiuA gene has pleiotropic functions that affect P. aeruginosa biofilm development and virulence. The targeting of FiuA
could enable the attenuation of P. aeruginosa virulence and may be suitable for the development of a drug that specifically
controls the virulence of this important pathogen.
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INTRODUCTION
Pseudomomas aeruginosa is the most common opportunis-
tic human pathogen. It produces various virulence factors,
including flagella, type IV pili, alkaline protease, elastase,
lipopolysaccharide, phospholipase, exotoxin A, pyoverdine and
pyochelin (Llamas et al. 2006). The expression of these var-
ious virulence determinants is regulated by complex signal
transduction systems in response to changes in the surrounding
environment.
A biofilm is defined as a community ofmicrobes that attaches
to certain surfaces and is normally covered with self-produced
extracellular materials (ECMs). Biofilm infections present high
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Table 1. Bacterial strains, plasmids and primers used in this study.
Strains, plasmids and primers Description Source
Bacterial strains
E. coli SM10/λpir Donor strain, Kmr, thi-1, thr, leu, tonA, lacY, supE, recA::RP4-2-Tc::Mu, kpir Lab collection
PAO1 Prototype P. aeruginosa laboratory strain Lab collection
fiuA PA01 with in-frame deletion of PA0470 gene This study
pchpvd Pyochelin and pyoverdine synthesis-defective PAO1 mutant Lab collection
Plasmids
pCVD442 sacB suicide vector generated from pUM24 Lab collection
pBTK30 Transposon vector for the construction of a random mutant library, Gmr (Kim et al. 2012)
pJN105c pJN105 with the gentamicin resistance marker replaced by a carbenicillin
resistance marker
(Min et al. 2014)
Primers
fiuA upstream (forward) 5′-AAAGAGCTCTACTGGGCGCTGGACATCA-3′
fiuA upstream (reverse) 5′-TTCCCGCACCGTTTCTCCAAGCTACAAGTGGTGAGCGACG-3′
fiuA downstream (forward) 5′- CGTCGCTCACCACTTGTAGCTTGGAGAAACGGTGCGGGAA-3′
fiuA downstream (reverse) 5′-AAAGAGCTCTCAAGGAA GGCCAGCAGGT-3′
resistance not only to antibiotics, but also to the host immune
response (Laarman et al. 2012; Gellatly and Hancock 2013; Rieber
et al. 2013). In addition, biofilms of microbial pathogens are a
major cause of chronic infection, and ∼80% of all microbial in-
fections are thought to be biofilm associated (Costerton, Stewart
and Greenberg 1999). Remarkably, microbes growing in biofilms
can be ∼1000 times more resistant to antibiotics than their
planktonic counterparts (Hoiby et al. 2010). To achieve this high
level of antibiotic resistance, biofilm-dwelling microbes use sev-
eral biofilm-specific mechanisms, such as physical ECM barri-
ers, persister cell formation and the starvation-induced stress
response (Hoiby et al. 2010; Mulcahy et al. 2010; Nguyen et al.
2011; Sievert et al. 2013). Additional antibiotic resistance mecha-
nisms of biofilms include glucan production and efflux pumps.
Ethanol oxidation, extracellular DNA and iron acquisition are
also thought to contribute to antibiotic resistance via as yet un-
characterized mechanisms (Zhang and Mah 2008; Hoiby et al.
2010; Sadovskaya et al. 2010; Mah 2012; Chen, Yu and Sun 2013).
The siderophores pyoverdine and pyochelin are known to play
particularly important roles in the evasion of the host im-
mune response and biofilm development (Shen et al. 2005; Nadal
Jimenez et al. 2010; Peek et al. 2012). The iron uptake system of
P. aeruginosa, which involves pyoverdin and pyochelin, has been
highly studied. However, information regarding the ferrichrome
uptake system in P. aeruginosa is very limited. Ferrichrome is a
heterologous hydroxamate siderophore that is involved in iron
acquisition along with pyoverdine and pyochelin in P. aeruginosa.
Approximately 80% of all ferrichrome is transferred into the cy-
toplasm through ferrichrome receptor protein A (FiuA) (Han-
nauer et al. 2010). As for ferripyoverdine and ferripyochelin, en-
ergy is required for ferrichrome to be transferred into the cyto-
plasm. This energy is supplied by an inner membrane protein,
TonB1 (Hoegy et al. 2005; Llamas et al. 2006; Hannauer et al. 2010).
TonB1 has been shown to be associated with quorum sensing,
which is closely linked to biofilm formation (Abbas et al. 2007).
Previous studies have also identified a link between biofilm for-
mation and iron acquisition (Nadal Jimenez et al. 2010; Smith
et al. 2013; Oglesby-Sherrouse et al. 2014).
Previous studies have shown that biofilm development by P.
aeruginosa is enhanced in the presence of subminimal inhibitory
concentration (sub-MIC) treatments of several antibiotics
(Hoffman et al. 2005; Wang et al. 2010; Kaplan 2011). However,
the genetic basis underlying this phenomenon has not yet been
discovered. In this study, we screened a P. aeruginosa transposon
mutant library to identify mutants that form defective biofilms
in the presence of sub-MIC carbenicillin. We found that a P.
aeruginosa mutant defective in the ferrichrome receptor A gene
(fiuA) exhibited a dramatic decrease in biofilm formation under
sub-MIC carbenicillin but not under non-antibiotic treated
conditions. Importantly, other indications of virulence were
also noticeably decreased when the fiuA gene was disrupted.
This information will potentially be useful in the development
of novel therapeutics against P. aeruginosa infection.
MATERIALS AND METHODS
Bacterial strains, plasmids, media and culture
conditions
All bacterial strains and plasmids used in this study are listed in
Table 1. Bacterial cultures were grown at 37◦C in Luria–Bertani
(LB) medium (10 g of tryptone, 5 g of yeast extract and 10 g of
NaCl per liter). To screen for biofilm-defective mutants at sub-
MICs, transposon-inserted bacterial strains were grown in 96-
well plates containing 100μl of LB with 9μg/ml carbenicillin.
Construction of the fiuA deletion mutant
The fiuA deletion mutant was created by allelic replacement as
previously described (Lee et al. 2012). Briefly, flanking sequences
(∼500 bp) at both ends of the fiuA gene locus were PCR amplified
with primers listed in Table 1. The SacI restriction sites are desig-
nated by underlining (Table 1). Two inner primers (upstream re-
verse primer and downstream forward primer) are complemen-
tary to each other. In this strategy, the 3′ end of the upstream
sequence and the 5′ end of the downstream sequence are able
to anneal during PCR amplification without further treatment.
The deletion of the fiuA gene was confirmed by PCR, and the re-
sultant strain was designated as fiuA.
Iron acquisition capability assay
The PAO1, fiuA and pchpvd mutants were incubated in LB
medium at 37◦C for 24 h. Siderophore activities in bacterial
supernatants were quantified using a SideroTec Kit (Emergen-
bio, Ireland), an assay kit that detects siderophore in a sample
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by color change. The assay kit is based on the chrome azurol
sulfonate (CAS) assay which was developed by Schwyn and Nei-
lands (1987). The blue reagent turns to purple or pinkwhen ferric
ion is transferred to siderophore, present in a sample.
Biofilm growth and quantification
Biofilms were prepared as previously described (O’Toole 2011).
Briefly, a static biofilm was prepared by inoculating LB-grown
bacterial strains (1:100 dilution) in LB or LB with carbenicillin in
96-well plates (SPL, Korea). The 96-well biofilm plates were incu-
bated at 37◦C for 24 h. Biofilm formation was quantified via the
crystal violet (CV) assay, described by O’Toole (O’Toole 2011). The
eluted CV stain was diluted (1:5) into a new 96-well plate and the
absorbance of each well was read at 550 nm (O’Toole 2011).
Confocal laser scanning microscopy (CLSM) image
analysis of biofilms
Differential interference contrast (DIC) imageswere acquired us-
ing a confocal laser scanningmicroscope (FV-1000; Olympus Op-
tical Co. Ltd, Japan) equippedwith FV10-ASWoperating software
(ver. 02.01). For CLSM image analysis, biofilms were prepared
in 96-well optical bottom plates with a coverglass base (Nunc,
MicroWell). After 24 h of biofilm growth, the planktonic portions
of the cultures were discarded and the wells were washed with
0.9% saline. Alternatively, biofilmswere grown in coverglass bot-
tom dishes (SPL, Korea) in the same manner as in the 96-well
plates. Biofilms were stained with a LIVE/DEAD BacLight Bac-
terial Viability kit (Invitrogen) and examined with two different
wavelength lasers, 488 nm and 594 nm. For three-dimensional
(3D) image analysis, Z-stack images were obtained and 3D im-
ages were reconstructed using FV10-ASW software.
Random transposon mutagenesis
For random transposon insertion mutagenesis, PAO1 was con-
jugated with Escherichia coli SM10/λpir cells harboring the
pBTK30 plasmid (Table 1) (Kim et al. 2012). Gentamicin-resistant
transconjugants were grown on LB agar plates containing
50μg/ml gentamicin and 50μg/ml Irgasan (Sigma). Approxi-
mately 5000 mutants were screened. All mutants defective in
biofilm development under sub-MIC carbenicillin treatments
were selected and their transposon insertion sites were deter-
mined by arbitrary PCR (Kim et al. 2012).
Elastase assay and Caenorhabditis elegans survival
assay
The level of elastase activity in bacterial culture supernatants
was assessed following procedures described elsewhere (Sen-
turk et al. 2012; Gi et al. 2014). The levels of elastase in the whole-
cell lysates and bacterial supernatants were assessed by prob-
ing membranes with anti-rabbit elastase antibody as a primary
antibody (Lee et al. 2011). A P. aeruginosa virulence assay using
C. elegans as an infection host was performed as described pre-
viously (Go et al. 2014). Briefly, overnight cultures of each bacte-
rial strain were diluted 100-fold into LB broth and cultured until
the OD600 value reached ∼1.0. Next, 10μl of E. coli OP50 (nega-
tive control strain), PAO1 and fiuA suspensions were spotted
onto Nematode Growth Media (NGM) agar plates. After 2 h in-
cubation at room temperature, each plate was seeded with 10
L4-stage hermaphroditeworms (three replicates per trial). Plates
were incubated at 20˚C. Live worms were transferred to a new
NGM plate and scored for mortality every 24 h.
Murine airway infection model for in vivo virulence
experiments
All animal experiments were approved by the Committee on
the Ethics of Animal Experiments of Yonsei University College
of Medicine (IACUC permit number: 2013-0369-5). To test the
virulence of the fiuA strain in vivo, 8-week-old C57BL/6N in-
bred female mice (Orient, Korea) were infected with each bac-
terial strain according to the acute infection protocol (Filloux
and Ramos 2014). Infections were conducted through the in-
tranasal route by making each mouse inhale 50μl of the appro-
priate bacterial culture dilution, applied in a dropwise manner
on the nose. Infected mice were returned to the cage and moni-
tored for labored respiration, loss of ability to ambulate and sur-
vival in every 4 h until 24 h, then euthanized by cervical dislo-
cation after anesthetization for histological observation of the
lungs at the humane endpoint. For histological staining, lungs
were perfused with sterile phosphate-buffered saline (PBS), and
hematoxylin and eosin (H&E) staining was performed according
to a standard protocol (Filloux and Ramos 2014). For the bacte-
rial burden measurement, another set of mice (n = 5) were in-
tranasally infected with 5 × 106 cells of PAO1 or fiuA, using the
samemethod as above. The lungs and spleens from the infected
mice were collected at 16 h after the infection. The harvested
left lobes of lungs and spleenswere homogenized, and the num-
bers of bacteria in the organ were measured by viable cell count
assay.
Statistical analysis
All data are expressed as means ± standard deviation (SD).
The unpaired Student’s t-test and one-way analysis of variance
(ANOVA) were used to analyze the significance of all compar-
isons. P-values <0.05 were considered to indicate statistical sig-
nificance. All experiments were repeated at least three times for
reproducibility.
RESULTS
Identification of a mutant defective in biofilm
development under sub-MIC carbenicillin
The screen for mutants defective in biofilm development under
sub-MIC antibiotic treatment conditions was conducted with
5000 transposon insertion mutants. All mutants that exhibited
growth defects were first eliminated from the screening. Next,
CV assays were performed for all mutants in 96-well plates, and
all biofilm-defective mutants were identified. All selected mu-
tants were validated in the second round of the CV assays. The
transposon insertion site of each selected mutant was deter-
mined by arbitrary PCR, followed by DNA sequencing (data not
shown). Twelve transposon-inserted mutants were left after the
growth and biofilm formation screening steps. Six out of the 12
mutants that showeddefective biofilm formation under sub-MIC
conditions have a transposon insertion in the genes known to af-
fect biofilm formation, such as pelA, pelD, flgK and gacA (data not
shown). Finally, the transposon mutant PATN715 was selected.
The ability of PATN715 to form biofilms was confirmed in nor-
mal and sub-MIC carbenicillin treatment conditions using the
CV assay (Fig. 1A) and CLSM image analysis (Fig. 1B). The PAO1
and PATN715 strains displayed similar levels of biofilm forma-
tion in LB medium. However, the PAO1 biofilm was increased
under sub-MIC carbenicillin treatment, whereas the PATN715
biofilm was decreased in this condition (Fig. 1A). Both CV
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Figure 1. Identification of a mutant defective in biofilm development under sub-MIC carbenicillin treatment. (A) Crystal violet biofilm assay of PAO1 (black bars) and
PATN715 (gray bars) strains grown in LB or LB with 9μg/ml carbenicillin for 24 h. Six replicates were performed; values are expressed as means ± SDs. ∗P < 0.001
vs. each biofilm grown in LB. (B) Transverse confocal scanning laser microscopy (CSLM) images and three-dimensional CSLM images of static biofilms of PAO1 and
PATN715 bacteria grown in LB or LB with 9μg/ml carbenicillin (x400). Biofilms were grown for 24 h.
Figure 2. fiuA deletion effect for growth and siderophore activity of P. aeruginosa.
(A) Growth rates of the PAO1 (solid line) and fiuA deletion mutant (fiuA, dot-
ted line) strains. Growth was measured by taking the optical density at 600 nm
(OD600 nm). Three replicates were performed; data are expressed as the mean ±
SD. (B) Siderophore assay of PAO1, fiuA and the pchpvd double mutant. The
color of the indicator reagent changes from blue to pinkwhen siderophores exist
in the samples. The number of replicates was three, and values of the mean ±
SD are displayed in each bar. ∗P < 0.001 vs. siderophore concentration of PAO1.
∗∗P < 0.05 vs. siderophore concentration of the pchpvd double mutant.
assay and CLSM analysis presented consistent results. In ad-
dition, CLSM image analysis showed bacterial cell elongation
in both PAO1 and PATN715 biofilms under antibiotic treatment
(Fig. 1B). The transposon was determined to be inserted at the
fiuA gene based on our arbitrary PCR, and its insertion was fur-
ther confirmed by PCR (data not shown). DNA sequencing re-
vealed that the transposon was inserted at 2039 bp downstream
from the 5′ end of the fiuA gene (data not shown).
Various virulence-associated phenotypes were affected
in fiuA, a fiuA clean deletion mutant
To better elucidate the effects of the fiuA gene on bacterial phe-
notypes, we constructed an in-frame deletionmutant of the fiuA
gene. Bacterial growth was not affected by the fiuA mutation
(Fig. 2A). Both strains, PAO1 and its fiuA mutant, entered the
exponential phase ∼4 h after inoculation. The doubling times of
the PAO1 and fiuA strains during the exponential phase were
∼1.8 h and 2 h, respectively.
To determine the role of fiuA in the iron acquisition, the
siderophore activity of PAO1 and fiuA was measured. The
qualitative indication for siderophore activity showed the color
changes of PAO1 from blue to pink and fiuA to purplish color,
but there was no color change in the pchpvd sample since
the pyochelin and pyoverdine are the major siderophores of P.
aeruginosa (Fig. 2B). The quantitative measure of siderophore
concentration presented a very low amount of siderophore
in the fiuA supernatant sample (Fig. 2B). The siderophore
concentration of the PAO1 supernatant was ∼10μg/ml,
whereas the concentration of the fiuA supernatant was
∼0.15μg/ml, and the concentration of pchpvd was close to
zero (Fig. 2B).
To determine precisely the role of fiuA in biofilm develop-
ment, biofilm developments of different siderophore mutants
in two different growth conditions, LB broth and LB broth with
sub-MIC carbenicillin, were quantified by the CV assay (Fig. 3A).
ThefiuA exhibited different patterns of biofilm formation in LB
and LB with sub-MIC carbenicillin compared with the PAO1 and
pchpvd strains. The PAO1 and pchpvd strains exhibited en-
hanced biofilmdevelopment in the presence of sub-MIC carbeni-
cillin, whereas the biofilm development of the fiuA strain was
significantly decreased under the same conditions. CLSM im-
age analysis of the biofilms yielded results consistent with those
from the CV assay (Fig 3B). CLSM Z-stack images revealed that
the PAO1 and pchpvd strains exhibited increased biofilm for-
mation in the presence of sub-MIC carbenicillin, whereas fiuA
biofilm formation was significantly decreased under the same
conditions. Moreover, the compositions of the PAO1 and fiuA
biofilms were different. Very few dead (red fluorescent) bacte-
rial cells were detected in the fiuA biofilm, whereas the PAO1
biofilm contained a considerable amount of dead bacterial cells
in its matrix (Fig. 3B).
To determine whether the fiuA strain exhibits any dif-
ference in virulence compared with the wild-type strain, the
amounts of elastase in the culture supernatants weremeasured.
Elastase is a major virulence factor produced by P. aeruginosa
that can be detected by SDS–PAGE as a major band migrating
at ∼33 kDa (Yoon et al. 2010). First, the Elastin Congo Red (ECR)
assay revealed that the fiuA supernatant contained a signifi-
cantly lower level of elastase activity compared with the PAO1
and pchpvd supernatants (Fig. 4A). Western blot analysis re-
vealed that the amounts of elastase in the whole-cell lysates
from the different strains were not significantly different. How-
ever, the amount of elastase in thefiuA supernatantwas clearly
decreased (Fig. 4B).
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Figure 3. Biofilm development of various P. aeruginosa siderophore mutants under sub-MIC carbenicillin treatments. (A) Effects of sub-MIC carbenicillin treatments
on biofilm development in PAO1 and siderophore mutant P. aeruginosa strains. Strains shown are PAO1 (black), fiuA (gray) and pchpvd (white). Six replicates were
performed; values are expressed as means ± SDs. ∗P < 0.001 vs. LB-grown biofilm. ∗∗P < 0.001 vs. biofilm levels of PAO1 and the pchpvd mutant in LB + 9μg/ml
carbenicillin. (B) Confocal laser scanning microscopy images of the biofilm development of the indicated P. aeruginosa strains with or without sub-MIC carbenicillin
treatment. Bacteria were grown in LB (top) or LB + 9μg/ml carbenicillin (bottom) for 24 h in a coverglass bottom dish (SPL, Korea). Magnification, ×400.
Figure 4. Decreased production of elastase by the P. aeruginosa fiuA deletion mu-
tant. (A) Elastin Congo Red (ECR) assay of the elastase activities in the super-
natants of PAO1 (black), fiuA (gray) and pchpvd (white) cultures. Three repli-
cates were performed; values are expressed as means ± SDs. (B) Western blot
analysis of the elastase levels in thewhole-cell lysates and supernatants of PAO1,
fiuA and pchpvd strains.
In vivo virulence of the fiuA mutant was attenuated
We next sought to understand how the deletion of the fiuA gene
affects the virulence of P. aeruginosa in vivo. For a preliminary
study of in vivo virulence, C. elegans was used as a model for
themulticellular eukaryotic organism. This experiment revealed
that the fiuA-fed C. elegans group has a higher survival rate
compared with the PAO1-fed C. elegans group (Fig. 5A). The av-
erage life spans of the PAO1-fed and fiuA-fed groups were 8.8
± 0.8 and 12.1 ± 0.8 days, respectively, indicating that C. elegans
grown on fiuA bacteria possessed a 37.5% longer life span than
those grown on PAO1 (Fig. 5A).
Likewise, mice (n = 5) infected with PAO1 or fiuA cells
(5.0 × 106 CFU) showed a contrasting survival rate. Two PAO1-
infectedmice perished at 22 h post-infection, whereas all fiuA-
infected mice survived up to 24 h (Fig. 5B). The survival assay
was terminated at 24 h post-infection, at which time all sur-
viving mice were euthanized for histological examination. H&E
staining revealed more leukocyte infiltration in the lung tissues
of PAO1-infected mice compared with those of fiuA-infected
mice (Fig. 5C). In addition to increased leukocyte infiltration,
PAO1-infectedmice also exhibited increased damage to the lung
connective tissue (Fig. 5C). Furthermore, the bacterial counts in
lungs of the mice revealed the definite difference in the infec-
tivity of PAO1 and fiuA. The average bacterial load in the lungs
of PAO1-infected mice (n = 5) was 4.08 × 109 CFU per left lobe
of lungs, whereas the average bacteria in the lungs of fiuA-
infected mice (n = 5) was 1.56 × 106 CFU per left lobe of lungs
(Fig. 5D). The average bacterial load in the spleens of PAO1-
infected mice (n = 5) was 1.14 × 107 CFU per spleen. Only one
fiuA-infected mouse presented a bacterial count of 3.33 × 104
CFU in its spleen, but bacterial cells were not recovered from the
spleen of the other four fiuA-infected mice (Fig. 5D).
DISCUSSION
A previous surveillance study revealed that antimicrobial usage
and antimicrobial resistance are strongly correlated with each
other (Xu et al. 2013). Bacterial resistance to antimicrobial agents
is often mediated by the formation of biofilm, a protective mode
of bacterial growth (Hoffman et al. 2005; Kaplan 2011). In this
study, we sought to identify further genetic determinants that
are responsible for antibiotic-inducible biofilm formation. Af-
ter performing a forward genetic screen and subsequent vali-
dation processes, we identified the fiuA gene, deletion of which
resulted in (i) defective biofilm formation under sublethal an-
tibiotic stress; (ii) reduced elastase secretion; and (iii) decreased
iron acquisition activity.
When PAO1 biofilm was treated with a subinhibitory con-
centration of imipenem, another β-lactam antibiotic, expres-
sion of genes encoding AmpC β-lactamase and proteins in-
volved in alginate biosynthesis was increased (Bagge et al. 2004).
Since alginate production occurs in the periplasmic space (Fata
Moradali et al. 2015) and β-lactamases, in their mature forms,
are also localized in the periplasm, it is highly likely that subin-
hibitory β-lactam treatment induces changes in the periplas-
mic environment. FiuA, as an outer membrane protein, inter-
acts with FiuR that is an inner membrane-bound periplasmic
protein (Hannauer et al. 2010). Therefore, these notions sug-
gest that (i) functional FiuA protein may participate in bacte-
rial responses to the subinhibitory β-lactam treatment by or-
chestrating the periplasmic reprogramming and (ii) the lack
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Figure 5. In vivo virulence analyses of the fiuA deletion mutant. (A) C. elegans survival curves of the PAO1-fed group (blue line) and the fiuA-fed group (green line),
and average life spans of each group of C. elegans. ∗P < 0.01 vs. the survival rate of the PAO1-fed worms. (B) Mouse survival rate following infection with PAO1 (circle)
or the fiuAmutant (square). (C) Histological analysis of H&E-stained lung tissues of intranasally infected mice with PAO1 are shown at ×20 and ×200 magnifications
(infection dose: 5.0 × 106 CFU). (D) Bacterial counts recovered from the left lobes of lungs and spleens. The infection dose was 5.0 × 106 cells per mouse of PAO1 or
fiuA. ∗P < 0.001 vs. the CFU of the PAO1-infected mice.
of FiuA results in broader consequences that include defec-
tive biofilm formation and reduced elastase secretion. Consis-
tent with this idea, the arr (aminoglycoside response regulator)
gene, encoding a membrane-anchored enzyme, plays an essen-
tial role in aminoglycoside-inducible biofilm formation (Hoff-
man et al. 2005). Collectively, bacterial responses that end up
with enhanced biofilm formation and altered virulence are prob-
ably accompanied by modifications of cell surface properties in
P. aeruginosa.
Elastase is a major virulence factor of P. aeruginosa that is
highly important for bacterial pathogenesis (Lee et al. 2011).
ECR assays showed that pyochelin and pyoverdine production
are not directly related to elastase production (Fig. 4A). West-
ern blot analysis confirmed the ECR results obtained with the
supernatants and also revealed that similar levels of elastase
were present in between the cell lysates of PAO1 and the mu-
tant strains (Fig. 4B). This result indicates that the production of
elastase itself is not affected in the mutant strain, but the mat-
uration of elastase may be affected by the deletion of the fiuA
gene.
The average life span of C. elegans under normal growth con-
ditions with E. coli OP50 bacteria is ∼10.5 days (Go et al. 2014).
We found that C. elegans fed on fiuA bacteria displayed an
even longer life span than C. elegans fed on E. coli OP50 (Fig. 5A).
Moreover, themice lung histology results confirm that the fiuA
strain has attenuated virulence, since the higher infiltration rate
indicates that the bacterial strain ismore virulent (Matute-Bello,
Frevert and Martin 2008) (Fig. 5C). Four out of five fiuA-infected
mice did not present bacterial infections in the spleens (Fig. 5D).
This indicates that the intranasal infection of fiuA is unlikely
to cause systemic infections.
Cumulatively, the data presented in this study reveal that
the fiuA gene, encoding for P. aeruginosa ferrichrome receptor A
(FiuA), has important functions in addition to its siderophore re-
ceptor function. Previous studies have proposed that P. aerugi-
nosa virulence is related to iron acquisition, but most of these
studies have focused on pyoverdine and pyochelin, or the ways
in which iron transport mechanisms can contribute to antibi-
otic efflux systems (Cuiv et al. 2007; Mettrick and Lamont 2009;
Imperi et al. 2010; Nadal Jimenez et al. 2010; Draper et al. 2011;
Peek et al. 2012; Oglesby-Sherrouse et al. 2014). These donot iden-
tify the precise role of ferrichrome itself. We identified a direct
relationship between FiuA and P. aeruginosa virulence. Specifi-
cally, we found that FiuA is involved in biofilm enhancement
under sub-MIC antibiotic treatment and also in elastase produc-
tion. However, the exact mechanisms underlying these results
are still under investigation.
While the murine airway infection model is a good represen-
tation of acute P. aeruginosa infection, this model may not ac-
curately represent chronic airway infections, which are the ma-
jor form of infections in patients with cystic fibrosis (Ciofu et al.
2012). Further studies of the fiuA deletion effects in chronic in-
fection models are necessary to understand fully FiuA involve-
ment in P. aeruginosa virulence. Despite these limitations, our
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results clearly demonstrate that FiuA is involved in the pro-
duction of various P. aeruginosa virulence factors. In conclusion,
this study identified new pleiotropic functions of P. aeruginosa
FiuA in biofilm formation, elastase activity and in vivo infectiv-
ity. FiuA was found to be dispensable for P. aeruginosa growth.
This is very important because the use of antibiotics that kill
bacteria is known to induce the emergence of new antibiotic-
resistant strains, which have the potential to threaten public
healthworldwide. Therefore, attenuating pathogen virulence in-
stead of killing pathogens is an attractive strategy for novel ther-
apeutics. By targeting FiuA, it may be possible to develop a drug
that specifically controls the pathogen virulence.
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